Model-informed dose selection for an investigational human epidermal growth factor receptor 2 antibody-drug conjugate FS-1502 in patients with human epidermal growth factor receptor 2-expressing advanced malignant solid tumours
Sun, Yi, Li, Chao, Wang, Xingli, Zheng, Yi, Wu, Zhuli, Hui, Ai-Min, Diao, Lei
Published in British journal of clinical pharmacology (01.04.2024)
Published in British journal of clinical pharmacology (01.04.2024)
Get full text
Journal Article
Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients
Richardson, Paul G., Baz, Rachid, Wang, Michael, Jakubowiak, Andrzej J., Laubach, Jacob P., Harvey, R. Donald, Talpaz, Moshe, Berg, Deborah, Liu, Guohui, Yu, Jiang, Gupta, Neeraj, Di Bacco, Alessandra, Hui, Ai-Min, Lonial, Sagar
Published in Blood (14.08.2014)
Published in Blood (14.08.2014)
Get full text
Journal Article
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis
Sanchorawala, Vaishali, Palladini, Giovanni, Kukreti, Vishal, Zonder, Jeffrey A., Cohen, Adam D., Seldin, David C., Dispenzieri, Angela, Jaccard, Arnaud, Schönland, Stefan O., Berg, Deborah, Yang, Huyuan, Gupta, Neeraj, Hui, Ai-Min, Comenzo, Raymond L., Merlini, Giampaolo
Published in Blood (03.08.2017)
Published in Blood (03.08.2017)
Get full text
Journal Article
Switching from body surface area‐based to fixed dosing for the investigational proteasome inhibitor ixazomib: a population pharmacokinetic analysis
Gupta, Neeraj, Zhao, Yuan, Hui, Ai‐Min, Esseltine, Dixie‐Lee, Venkatakrishnan, Karthik
Published in British journal of clinical pharmacology (01.05.2015)
Published in British journal of clinical pharmacology (01.05.2015)
Get full text
Journal Article
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
Kumar, Shaji K, Prof, Berdeja, Jesus G, MD, Niesvizky, Ruben, Prof, Lonial, Sagar, Prof, Laubach, Jacob P, MD, Hamadani, Mehdi, MD, Stewart, A Keith, Prof, Hari, Parameswaran, Prof, Roy, Vivek, MD, Vescio, Robert, MD, Kaufman, Jonathan L, MD, Berg, Deborah, MSN, Liao, Eileen, PhD, Di Bacco, Alessandra, PhD, Estevam, Jose, BSc, Gupta, Neeraj, PhD, Hui, Ai-Min, MD, Rajkumar, Vincent, Prof, Richardson, Paul G, Prof
Published in The lancet oncology (01.12.2014)
Published in The lancet oncology (01.12.2014)
Get full text
Journal Article
Isatuximab plus pomalidomide/dexamethasone versus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma: ICARIA Phase III study design
Richardson, Paul G, Attal, Michel, Campana, Frank, Le-Guennec, Solenn, Hui, Ai-Min, Risse, Marie-Laure, Corzo, Kathryn, Anderson, Kenneth C
Published in Future oncology (London, England) (01.05.2018)
Published in Future oncology (London, England) (01.05.2018)
Get full text
Journal Article
Pharmacokinetics, Safety, and Tolerability of Tenapanor in Healthy Chinese and Caucasian Volunteers: A Randomized, Open-Label, Single-Center, Placebo-Controlled Phase 1 Study
Yuan, Gang, Chen, Yili, Li, Li, Wang, Xin, Wei, Gang, Zeng, Jiawei, Hui, Ai-Min, Jiang, Yueyun, Zhao, Han, Diao, Lei, Zhou, Yongchun, Xiao, Yinglian, Chen, Minhu
Published in International journal of clinical practice (Esher) (2024)
Published in International journal of clinical practice (Esher) (2024)
Get full text
Journal Article
The Effect of a High‐Fat Meal on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or Lymphoma
Gupta, Neeraj, Hanley, Michael J., Venkatakrishnan, Karthik, Wang, Bingxia, Sharma, Sunil, Bessudo, Alberto, Hui, Ai‐Min, Nemunaitis, John
Published in Journal of clinical pharmacology (01.10.2016)
Published in Journal of clinical pharmacology (01.10.2016)
Get full text
Journal Article
Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromas
Hu, Xiaojie, Li, Wenbin, Zeng, Kang, Xu, Zhongyuan, Li, Changxing, Kang, Zhuang, Li, Shenglan, Huang, Xin, Han, Pu, Lin, Hongmei, Hui, Ai-Min, Tan, Yan, Diao, Lei, Li, Ben, Wang, Xingli, Wu, Zhuli, Lin, Xiaoxi
Published in BMC medicine (03.07.2023)
Published in BMC medicine (03.07.2023)
Get full text
Journal Article
A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end‐stage renal disease requiring haemodialysis
Gupta, Neeraj, Hanley, Michael J., Harvey, R. Donald, Badros, Ashraf, Lipe, Brea, Kukreti, Vishal, Berdeja, Jesus, Yang, Huyuan, Hui, Ai‐Min, Qian, Mark, Zhang, Xiaoquan, Venkatakrishnan, Karthik, Chari, Ajai
Published in British journal of haematology (01.09.2016)
Published in British journal of haematology (01.09.2016)
Get full text
Journal Article
A Phase I Dose-Escalation and Dose-Expansion Study of FCN-437c, a Novel CDK4/6 Inhibitor, in Patients with Advanced Solid Tumors
Patnaik, Amita, Hamilton, Erika, Xing, Yan, Rasco, Drew W, Smith, Lon, Lee, Ya-Li, Fang, Steven, Wei, Jiao, Hui, Ai-Min
Published in Cancers (01.10.2022)
Published in Cancers (01.10.2022)
Get full text
Journal Article
Effect of High-Fat Food on the Pharmacokinetic Profile and Safety of SAF-189s, an ALK/ROS1 Inhibitor, in Healthy Chinese Adults
Qin, Huiling, Tan, Yan, Diao, Lei, Hui, Ai-Min, Wu, Zhuli, Zhou, Yongchun, Sun, Juan, Xiang, Xiao, Qiu, Jingjun, Hu, Wei
Published in Drugs in R&D (01.12.2023)
Published in Drugs in R&D (01.12.2023)
Get full text
Journal Article
Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial
Hui, Ai-Min, Li, Jingxin, Zhu, Li, Tang, Rong, Ye, Huayue, Lin, Mei, Ge, Lei, Wang, Xiyuan, Peng, Fuzhong, Wu, Zhenggang, Guo, Xiling, Shi, Yunfeng, Pan, Hongxing, Zhu, Jiahong, Song, Zhizhou, Qiu, Jingjun, Wang, Wei, Zheng, Jianfei, Ozhelvaci, Orkun, Shpyro, Svetlana, Bushway, Meghan, Derhovanessian, Evelyna, Kühnle, Marie-Cristine, Luxemburger, Ulrich, Muik, Alexander, Shishkova, Yoana, Khondker, Zakaria, Hu, Simin, Lagkadinou, Eleni, Şahin, Uğur, Türeci, Özlem, Zhu, Fengcai
Published in The Lancet regional health. Western Pacific (01.12.2022)
Published in The Lancet regional health. Western Pacific (01.12.2022)
Get full text
Journal Article
Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study
Gupta, Neeraj, Goh, Yeow Tee, Min, Chang-Ki, Lee, Jae Hoon, Kim, Kihyun, Wong, Raymond S M, Chim, Chor Sang, Hanley, Michael J, Yang, Huyuan, Venkatakrishnan, Karthik, Hui, Ai-Min, Esseltine, Dixie-Lee, Chng, Wee Joo
Published in Journal of hematology and oncology (04.09.2015)
Published in Journal of hematology and oncology (04.09.2015)
Get full text
Journal Article
The investigational proteasome inhibitor ixazomib for the treatment of multiple myeloma
Richardson, Paul G, Moreau, Philippe, Laubach, Jacob P, Gupta, Neeraj, Hui, Ai-Min, Anderson, Kenneth C, San Miguel, Jesús F, Kumar, Shaji
Published in Future oncology (London, England) (01.04.2015)
Published in Future oncology (London, England) (01.04.2015)
Get full text
Journal Article